Evaxion Biotech AS share price logo

Evaxion Biotech AS Share Price

NASDAQ: EVAX

Small Cap

$4.14

as on

Evaxion Biotech AS Stock Performance

as on April 16, 2026 at 6:57 am IST

  • Day's Low

    $3.97
    $4.14
    downward going graph

    4.11%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.25
    $12.15
    downward going graph

    69.81%

    Downside

    193.48%

    Upside

    downward going graph

Evaxion Biotech AS share price movements today

Previous Close
$4.14
Open
$4.13
Volume
482.0K
Day's Low - High
$3.97 - $4.14
52 Week Low - High
$1.25 - $12.15

Evaxion Biotech AS Historical Returns

1 Month Return
+ 8.38 %
3 Month Return
-9.01 %
1 Year Return
+ 216.03 %
3 Year Return
-94.69 %
5 Year Return
-98.73 %

Evaxion Biotech AS Stock Fundamentals & Key Indicators

Check Evaxion Biotech AS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$34.5M

EPS (TTM)

-0.025

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-8.9M

Revenue (TTM)

7.5M

Profit Margin

-102.38%

Return On Equity TTM

-100.18%

Evaxion Biotech AS vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evaxion Biotech AS with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$34.5M-98.73%NA-102.38%
BUY$44.5B140.06%143.098.45%
BUY$112.4B101.33%28.8132.94%
NA$36.7BNA124.985.37%
BUY$79.7B50.01%18.1831.41%

Stock Returns calculator for Evaxion Biotech AS Stock including INR - Dollar returns

The Evaxion Biotech AS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Evaxion Biotech AS investment value today

Current value as on today

₹3,44,524

Returns

₹2,44,524

(+244.52%)

Returns from Evaxion Biotech AS Stock

₹2,16,031 (+216.03%)

Dollar Impact

₹28,493 (+28.49%)

Analyst Recommendation on Evaxion Biotech AS Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Evaxion Biotech AS. Average target price of $11.25

Evaxion Biotech AS Share Price Target

Get share price movements and forecasts by analysts on Evaxion Biotech AS.

What analysts predicted

63.2%UPSIDE

Target Price

$11.25

Current Price

$4.14

Analyzed by

9 Analysts

Target

$11.25

Evaxion Biotech AS target price $11.25, a slight upside of 63.2% compared to current price of $4.14. According to 9 analysts rating.

Evaxion Biotech AS Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
0
0
3
0
0
0
7
0
Gross Profit
-
0
0
0
3
-
0
0
7
-7
Operating Income
-5
-4
-4
-4
-1
-4
-3
-4
3
-4
EBITDA
-5
-4
1
-6
-1
-
-1
-4
5
-8
Interest Expense
0
0
0
0
0
-1
0
0
1
1
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-5
-4
0
-6
-2
-3
-1
-5
4
-6
Income Tax Expense
0
0
0
0
0
-
0
0
0
0
Net Income
-5
-4
1
-6
-1
-3
-1
-4
4
-5
Net Profit Margin
0.00%
-6195.89%
2346.65%
-4024.68%
-64.14%
-2974.59%
-1295.08%
-13056.76%
61.64%
-26940.05%

Evaxion Biotech AS Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
3
7
Gross Profit
0
0
0
0
0
0
3
7
Operating Income
-5
-11
-16
-25
-25
-22
-14
-9
EBITDA
-6
-11
-16
-24
-22
-21
-9
-8
Interest Expense
0
1
0
0
1
0
0
0
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-6
-12
-16
-24
-23
-22
-11
-8
Income Tax Expense
0
0
-1
0
0
0
0
0
Net Income
-5
-11
-15
-24
-23
-22
-10
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-30308.22%
-316.00%
-102.38%

Evaxion Biotech AS Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-4
1
-6
-1
-3
-1
-4
4
-5
Operating Cash Flow
-2
-
-
-
-
-
-
-
-6
Investing Cash Flow
0
-
-
-
-
-
-
-
0
Financing Cash Flow
5
-
-
-
-
-
-
-
22
Change in Cash
2
-
-
-
-
1
-
-
23

Evaxion Biotech AS Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-15
-24
-23
-22
-10
-7
Operating Cash Flow
-7
-12
-21
-25
-17
-12
-6
Investing Cash Flow
0
0
-1
0
0
0
0
Financing Cash Flow
9
8
49
7
10
13
22
Change in Cash
2
-3
26
-18
-7
0
17

Global Institutional Holdings in Evaxion Biotech AS

Funds
Holdings
Point72 Asset Management, L.P.
0.4%
Stonepine Capital Management Llc
0.24%
SBI Securities Co Ltd
0%
EverSource Wealth Advisors, LLC
0.03%
Ikarian Capital, LLC
0.96%

Evaxion Biotech AS News & Key Events

  • img

    Today's Timeline - 03 October

    Fri, 06:30 PM

    -

    Evaxion to present new biomarker data for EVX-01 at SITC 2025 Annual Meeting and ESMO 2025 congress.

Insights on Evaxion Biotech AS

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, EVAX stock has moved up by 216.0%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EVAX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 66.4% return, outperforming this stock by 161.1%

About Evaxion Biotech AS

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.
OrganisationEvaxion Biotech AS
HeadquartersDr. Neergaards Vej, Horsholm, Denmark, 2970
IndustryBiotechnology
CEODr. Helen Katrina Tayton-Martin MBA, Ph.D.
E-voting on sharesClick here to vote

Key Management of Evaxion Biotech AS

Name

Title

Dr. Birgitte Rono Ph.D.

Chief Scientific Officer

Mr. Benjamin Ole Wolthers

Vice President of Clinical Development

Dr. Helen Katrina Tayton-Martin MBA, Ph.D.

Chief Executive Officer

Mr. Andreas Holm Mattsson M.Sc.

Founder & Chief AI Officer

Mr. Thomas Frederik Schmidt M.Sc.

Chief Financial Officer

FAQs

What is Evaxion Biotech AS share price today?

Evaxion Biotech AS share price today is $4.14 as on at the close of the market. Evaxion Biotech AS share today touched a day high of $4.14 and a low of $3.97.

What is the 52 week high and 52 week low for Evaxion Biotech AS share?

Evaxion Biotech AS share touched a 52 week high of $12.15 on and a 52 week low of $1.25 on . Evaxion Biotech AS stock price today i.e. is closed at $4.14,which is 65.93% down from its 52 week high and 231.20% up from its 52 week low.

What is Evaxion Biotech AS's market capitalisation today?

Evaxion Biotech AS market capitalisation is $0.00T as on .

How to invest in Evaxion Biotech AS Stock (EVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evaxion Biotech AS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evaxion Biotech AS Shares that will get you 0.3623 shares as per Evaxion Biotech AS share price of $4.14 per share as on April 16, 2026 at 1:27 am IST.

What is the minimum amount required to buy Evaxion Biotech AS Stock (EVAX) from India?

Indian investors can start investing in Evaxion Biotech AS (EVAX) shares with as little as ₹93.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹934.36 in Evaxion Biotech AS stock (as per the Rupee-Dollar exchange rate as on ). Based on Evaxion Biotech AS share’s latest price of $4.14 as on April 16, 2026 at 1:27 am IST, you will get 2.4155 shares of Evaxion Biotech AS. Learn more about fractional shares .

What are the returns that Evaxion Biotech AS has given to Indian investors in the last 5 years?

Evaxion Biotech AS stock has given -98.73% share price returns and 24.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?